학술논문
Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Document Type
Article
Author
Source
In The Lancet HIV June 2019 6(6):e355-e363
Subject
Language
ISSN
2352-3018